immunotherapy

You have access
Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer
Jean-François Rossi, Patrick Frayssinet, Maksim Matciyak and Nikolai Tupitsyn

Cancer Biology & Medicine December 2023, 20 (12) 1021-1034; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0222
You have access
Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?
Lin Ma, Liufu Deng, Jianfeng Peng, Jinming Yu and Xiangjiao Meng

Cancer Biology & Medicine December 2023, 20 (12) 1035-1046; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0402
You have access
Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors
Qingxu Liu, Long Li, Wan Qin and Tengfei Chao

Cancer Biology & Medicine November 2023, 20 (11) 856-868; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0281
You have access
Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
Juan Hui, Mingzhen Zhou, Guangzhou An, Hui Zhang, Yuanyuan Lu, Xin Wang and Xiaodi Zhao

Cancer Biology & Medicine August 2023, 20 (8) 575-598; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0119
You have access
Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
Tiancheng Zhang, Youpei Lin and Qiang Gao

Cancer Biology & Medicine March 2023, 20 (3) 181-195; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0002
You have access
Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment
Pengfei Zhu, Hongrui Lu, Mingxing Wang, Ke Chen, Zheling Chen and Liu Yang

Cancer Biology & Medicine January 2023, 20 (1) 44-55; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0491
You have access
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives
Rilan Bai, Wenqian Li and Jiuwei Cui

Cancer Biology & Medicine December 2022, 19 (12) 1649-1661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0489
You have access
Targeting PP2A for cancer therapeutic modulation
Halle Ronk, Jared S. Rosenblum, Timothy Kung and Zhengping Zhuang

Cancer Biology & Medicine October 2022, 19 (10) 1428-1439; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0330
You have access
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu

Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708
You have access
Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
Wuyin Wang, Lu Zhang and Zhijun Sun

Cancer Biology & Medicine July 2022, 19 (7) 948-964; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0049

Main menu

User menu

Search

immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services